Virtu Financial’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Virtu Financial’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$118K	Buy	+287,972	New	+$478K	0.01%	1055
2019 Q3	–	Sell	-11,529	Closed	-$25K	–	2019
2019 Q2	$25K	Buy	+11,529	New	+$29.5K	﹤0.01%	1324
2018 Q4	–	Sell	-10,088	Closed	-$41K	–	2170
2018 Q3	$41K	Buy	+10,088	New	+$44.5K	﹤0.01%	1326
2018 Q1	–	Sell	-11,693	Closed	-$18K	–	2919
2017 Q4	$18K	Sell	11,693 -15,965	-58%	-$25.6K	﹤0.01%	2234
2017 Q3	$59K	Buy	+27,658	New	+$94.1K	﹤0.01%	2204

Other funds holding CORV

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial's CORV Position: Q4 2019 in Review

Virtu Financial opened a new position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019: 287,972 shares worth $118K. The stake represents 0.01% of the portfolio and ranks #1055 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CORV as recently as Q2 2019.

Virtu Financial first reported a position in CORV in Q3 2017 and has held it in 5 quarters since. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

Virtu Financial held 287,972 shares of Correvio Pharma Corp. Ordinary Shares (Canada) worth $118K as of Q4 2019.
Correvio Pharma Corp. Ordinary Shares (Canada) was a new Virtu Financial position in Q4 2019.
Correvio Pharma Corp. Ordinary Shares (Canada) made up 0.01% of Virtu Financial's portfolio in Q4 2019, its #1055 holding.
Virtu Financial first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2017 and has held it in 5 quarters since.
31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.